Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.75 [0.64-0.88],0.000429076752709141,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RSPO3,R-spondin-3,Inverse variance weighted,6,0.79 [0.67-0.92],0.0030641268600865,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,REN,Renin,Inverse variance weighted,4,1.17 [1.04-1.31],0.00885239665155072,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.79 [0.65-0.96],0.0170815752189283,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.81 [0.68-0.96],0.017742777668046,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,APCS,Serum amyloid P-component,Inverse variance weighted,4,1.16 [1.02-1.32],0.0194073272624058,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.95 [0.9-0.99],0.0207298975021373,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,2.23 [1.11-4.51],0.0250144961637557,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,COLEC12,Collectin-12,Inverse variance weighted,11,0.88 [0.79-0.99],0.0305954585671913,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,F10,Coagulation factor X,Inverse variance weighted,9,1.05 [1-1.1],0.0369922022846696,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.87 [0.75-1],0.0511135045902487,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,OGN,Mimecan,Inverse variance weighted,30,0.94 [0.88-1],0.0528927055984345,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.94 [0.89-1],0.0531856973568504,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.84 [0.7-1],0.0564679611146645,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.94 [0.87-1],0.0630912860732264,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.04 [1-1.08],0.0710549024111797,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.56 [0.96-2.53],0.0717828286432788,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.88 [0.76-1.01],0.0725881537153395,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NECTIN2,Nectin-2,Inverse variance weighted,5,0.92 [0.85-1.01],0.0733678392102902,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.86 [0.73-1.01],0.0741800505008922,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.2 [0.98-1.48],0.0840277142703681,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.84 [0.68-1.03],0.0958682602513425,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.03 [0.99-1.07],0.097976617145362,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPON1,Spondin-1,Inverse variance weighted,21,1.07 [0.99-1.16],0.0986316080699516,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.09 [0.98-1.2],0.0986821256490308,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.93 [0.85-1.01],0.10089541906793,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LMNB2,Lamin-B2,Wald ratio,1,0.54 [0.26-1.13],0.102816379523703,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.06 [0.99-1.13],0.103806930262243,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL15,Interleukin-15,Wald ratio,1,0.1 [0.01-1.72],0.114004810103143,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,VWC2,Brorin,Inverse variance weighted,22,1.07 [0.98-1.16],0.115382220062633,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NFASC,Neurofascin,Inverse variance weighted,15,0.94 [0.88-1.01],0.116166554880212,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.03 [0.99-1.07],0.122975735690433,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.8 [0.6-1.06],0.123033285572806,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SDC1,Syndecan-1,Inverse variance weighted,2,0.81 [0.62-1.06],0.123411466928258,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,KLK4,Kallikrein-4,Inverse variance weighted,17,1.06 [0.98-1.14],0.124214471799958,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.06 [0.98-1.15],0.125107393946286,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.8 [0.84-3.83],0.130371961231619,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.14 [0.96-1.36],0.133833442728748,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.03 [0.99-1.08],0.134376400629409,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.1 [0.97-1.24],0.139942651895252,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.1 [0.97-1.25],0.148694727958952,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.9 [0.78-1.04],0.149604261268176,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.77 [0.53-1.1],0.149991678862426,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.98 [0.94-1.01],0.150511930478917,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.94 [0.87-1.02],0.158112913660991,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.07 [0.97-1.19],0.166998828750205,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.94 [0.85-1.03],0.168821334794552,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.11 [0.96-1.28],0.173913206726922,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHGB,Secretogranin-1,Inverse variance weighted,27,0.97 [0.92-1.02],0.182715812435615,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.13 [0.94-1.34],0.192817182270834,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.05 [0.98-1.12],0.196547998204771,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.05 [0.98-1.12],0.196637628446059,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.05 [0.98-1.12],0.197220565434531,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD27,CD27 antigen,Inverse variance weighted,9,1.06 [0.97-1.16],0.199723783131024,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.38 [0.84-2.27],0.209287972716465,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.84 [0.64-1.1],0.212228757304393,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.84 [0.63-1.11],0.216456779933273,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LAYN,Layilin,Inverse variance weighted,20,0.94 [0.85-1.04],0.219775664728974,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.84 [0.64-1.11],0.220457569460734,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.8 [0.55-1.15],0.222351630628419,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.09 [0.95-1.24],0.226091589524281,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.92 [0.8-1.05],0.226209357262895,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.17 [0.9-1.53],0.227593898244834,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,OCLN,Occludin,Inverse variance weighted,2,1.15 [0.91-1.45],0.235851675671821,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.93 [0.82-1.05],0.243331308264462,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LGALS9,Galectin-9,Inverse variance weighted,26,1.04 [0.97-1.11],0.2562442804797,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.1 [0.93-1.31],0.256790235652086,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.62 [0.27-1.43],0.261319407774096,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SEPTIN8,Septin-8,Inverse variance weighted,2,0.89 [0.72-1.1],0.271755607426558,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.1 [0.93-1.3],0.277133665213748,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,F7,Coagulation factor VII,Inverse variance weighted,21,1.04 [0.97-1.11],0.280075305706289,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CDH2,Cadherin-2,Inverse variance weighted,3,1.19 [0.87-1.62],0.280322958429945,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LCAT,Phosphatidylcholine-sterol acyltransferase,Wald ratio,1,1.16 [0.88-1.53],0.285259060956476,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,1.06 [0.95-1.18],0.291198199097262,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PALM2,Paralemmin-2,Inverse variance weighted,8,1.07 [0.94-1.21],0.296047334408406,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.97 [0.91-1.03],0.306397518043721,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.94 [0.84-1.06],0.307646620569386,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.09 [0.92-1.3],0.319190164684015,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.12 [0.89-1.41],0.320352113831808,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.94 [0.84-1.06],0.321198403523915,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.97 [0.92-1.03],0.323439968311368,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.04 [0.96-1.13],0.332684592732998,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PSAP,Prosaposin,Inverse variance weighted,5,0.9 [0.73-1.11],0.334435049089217,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.96 [0.89-1.04],0.338053723463219,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.3 [0.75-2.22],0.347933904559208,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DSC2,Desmocollin-2,Inverse variance weighted,9,0.95 [0.86-1.05],0.350421853609202,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.05 [0.95-1.16],0.362747083441595,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.07 [0.92-1.25],0.367652677019422,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ANXA10,Annexin A10,Wald ratio,1,1.31 [0.72-2.37],0.372546859218196,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.5 [0.11-2.27],0.372762821292842,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.98 [0.93-1.03],0.375117133893504,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MMP7,Matrilysin,Inverse variance weighted,13,0.97 [0.89-1.05],0.391819507372403,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.97 [0.89-1.05],0.397235282038142,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.06 [0.92-1.21],0.407246059827948,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PGF,Placenta growth factor,Inverse variance weighted,2,0.56 [0.14-2.23],0.408678749984969,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.12 [0.85-1.49],0.424036667426613,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.02 [0.96-1.09],0.424819849045052,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.04 [0.94-1.16],0.426817778625269,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.08 [0.89-1.3],0.431495464877011,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,1.02 [0.97-1.06],0.437933389066064,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.03 [0.96-1.1],0.451266396332381,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.05 [0.92-1.2],0.453044813780755,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.02 [0.96-1.09],0.454818239401989,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.16 [0.79-1.7],0.462992030491338,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.08 [0.88-1.31],0.467127375030223,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.09 [0.86-1.38],0.469211428471048,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PTN,Pleiotrophin,Inverse variance weighted,4,1.1 [0.85-1.42],0.474223351706529,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,1.08 [0.87-1.35],0.486779631488457,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.97 [0.87-1.07],0.492005318018322,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.03 [0.94-1.12],0.496421592323238,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.12 [0.8-1.57],0.503260020380588,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.03 [0.95-1.11],0.503638694624388,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHGA,Chromogranin-A,Inverse variance weighted,3,0.95 [0.81-1.11],0.50688467293357,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CTSL,Cathepsin L1,Wald ratio,1,0.8 [0.41-1.55],0.509865744121807,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.03 [0.95-1.11],0.512522632041607,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.34 [0.55-3.25],0.513816142313241,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NRP1,Neuropilin-1,Inverse variance weighted,12,0.97 [0.9-1.06],0.533775121343354,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.94 [0.77-1.15],0.540273928597936,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.92 [0.69-1.22],0.549499581999772,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.09 [0.82-1.44],0.56453300092612,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.97 [0.87-1.08],0.566293583436149,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.03 [0.92-1.16],0.571194228459984,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.98 [0.92-1.05],0.573515905007808,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,0.98 [0.93-1.04],0.574289483130605,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.05 [0.89-1.23],0.574514186508974,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.76 [0.29-1.98],0.578352057230994,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,0.94 [0.74-1.18],0.58136551104664,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GUCA2A,Guanylin,Inverse variance weighted,9,0.96 [0.84-1.1],0.588388719907796,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AMBP,Protein AMBP,Inverse variance weighted,3,1.06 [0.87-1.29],0.589330768600318,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.02 [0.95-1.09],0.592490936792786,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.98 [0.93-1.04],0.59292685257664,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.02 [0.96-1.07],0.592942785965604,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EPO,Erythropoietin,Inverse variance weighted,5,1.14 [0.7-1.84],0.601240003487142,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.97 [0.88-1.08],0.610363336914269,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.08 [0.8-1.47],0.612020811526348,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.09 [0.77-1.55],0.621901086657868,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.03 [0.91-1.16],0.634977706158548,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.03 [0.9-1.18],0.64021863453651,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.02 [0.94-1.11],0.643366334865119,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AGRN,Agrin,Inverse variance weighted,17,0.98 [0.88-1.08],0.647348377162239,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.03 [0.9-1.19],0.659266359145971,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.03 [0.9-1.18],0.661523679659703,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPON2,Spondin-2,Inverse variance weighted,4,0.97 [0.85-1.11],0.663261800487453,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NRP2,Neuropilin-2,Inverse variance weighted,11,0.98 [0.88-1.08],0.665101407584689,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,C7,Complement component C7,Inverse variance weighted,38,1.01 [0.97-1.05],0.671898465611307,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,0.98 [0.89-1.07],0.67481870238099,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.92 [0.64-1.34],0.675415688058576,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.95 [0.76-1.2],0.679641529952668,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CSTB,Cystatin-B,Inverse variance weighted,28,0.99 [0.93-1.05],0.680361339042709,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.03 [0.9-1.17],0.693101835318971,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.96 [0.8-1.16],0.695050453055592,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.02 [0.91-1.15],0.695395446168646,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.99 [0.92-1.06],0.699801470446077,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EDN1,Endothelin-1,Inverse variance weighted,3,0.95 [0.73-1.24],0.708788918435969,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.98 [0.9-1.07],0.719449620648094,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.06 [0.77-1.46],0.720949334085111,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.98 [0.87-1.1],0.721491966143502,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.99 [0.92-1.06],0.721693939280008,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.04 [0.84-1.28],0.724753721584329,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.92 [0.58-1.45],0.724832462029754,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.07 [0.75-1.52],0.725950246313646,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GHR,Growth hormone receptor,Inverse variance weighted,38,0.99 [0.96-1.03],0.726078592319829,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.96 [0.75-1.22],0.729875394438264,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD302,CD302 antigen,Inverse variance weighted,9,1.02 [0.92-1.13],0.740914717644403,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.12 [0.55-2.3],0.746768591947665,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.98 [0.85-1.13],0.749777322374858,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CST3,Cystatin-C,Inverse variance weighted,10,0.98 [0.89-1.08],0.749953793135717,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.93 [0.59-1.46],0.754002638406147,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PRSS8,Prostasin,Inverse variance weighted,5,1.05 [0.78-1.41],0.756046780758964,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.99 [0.94-1.05],0.765122532040895,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.98 [0.88-1.1],0.777816724639071,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.99 [0.95-1.04],0.787272321605274,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.01 [0.94-1.08],0.795747261164003,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.01 [0.91-1.12],0.797037313439758,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.99 [0.9-1.08],0.808170262660764,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.02 [0.89-1.16],0.814967279973151,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.06 [0.66-1.69],0.818474684071025,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.02 [0.88-1.17],0.819182826776898,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.89-1.16],0.820733379646307,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.01 [0.92-1.11],0.826080834246456,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EGFLAM,Pikachurin,Inverse variance weighted,19,0.99 [0.94-1.05],0.834647523434108,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.04 [0.72-1.49],0.846044468368099,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LGALS4,Galectin-4,Inverse variance weighted,4,1.02 [0.84-1.23],0.85201350989773,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.01 [0.92-1.1],0.855691930953569,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.96 [0.63-1.46],0.856581150186935,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.02 [0.83-1.25],0.858808714503606,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.01 [0.9-1.13],0.866320143059299,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1 [0.95-1.06],0.872751385238522,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.01 [0.94-1.07],0.875301845966239,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.98 [0.7-1.36],0.881665815244797,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.99 [0.8-1.22],0.889744184944276,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.02 [0.78-1.34],0.893970440074615,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.99 [0.84-1.17],0.894595387797329,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.98 [0.76-1.28],0.89573849447981,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,0.99 [0.85-1.15],0.903163252225771,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AREG,Amphiregulin,Inverse variance weighted,3,0.99 [0.81-1.2],0.905051186887633,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,10,0.99 [0.9-1.1],0.907556484327171,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.01 [0.79-1.31],0.909861000661158,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.97 [0.58-1.62],0.910848042884364,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.01 [0.79-1.31],0.910950642432075,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1 [0.95-1.06],0.922451724264964,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,1 [0.89-1.12],0.946672226404266,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1 [0.94-1.06],0.947129896353765,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1 [0.92-1.09],0.953267196125921,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.98 [0.44-2.16],0.953344267778191,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLEC3B,Tetranectin,Inverse variance weighted,7,1 [0.86-1.16],0.954036525602831,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1 [0.92-1.09],0.956435862090481,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.99 [0.76-1.3],0.956494865221744,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1 [0.88-1.12],0.959632781056927,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.91-1.1],0.96666949387292,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1 [0.81-1.23],0.96699802423338,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1 [0.93-1.07],0.968048826754099,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1 [0.86-1.16],0.97806096003595,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1 [0.67-1.49],0.990817568399874,cis
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.72 [0.58-0.88],0.00121518131788336,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,VWC2,Brorin,Inverse variance weighted,12,1.43 [1.13-1.81],0.00282286490697744,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.1 [1.03-1.16],0.00378321173747956,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.17 [1.05-1.31],0.00557374797567916,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.77 [0.63-0.93],0.00596574400063624,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.75 [0.61-0.93],0.00737516226581409,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.21 [1.05-1.4],0.0100550778153128,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL15,Interleukin-15,Inverse variance weighted,35,0.86 [0.77-0.97],0.0101111827455811,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.76 [0.6-0.97],0.0270561605300604,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,C7,Complement component C7,Inverse variance weighted,26,1.07 [1.01-1.13],0.0324210833218001,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,OGN,Mimecan,Inverse variance weighted,37,0.93 [0.87-1],0.0373119170063474,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.86 [0.75-0.99],0.0390987529565436,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,OCLN,Occludin,Inverse variance weighted,2,1.57 [1.02-2.41],0.0396330017616252,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LGALS4,Galectin-4,Inverse variance weighted,15,0.92 [0.86-1],0.0425501571287804,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.32 [1-1.75],0.0486935756588673,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.27 [1-1.61],0.0543977124528357,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,2.04 [0.98-4.27],0.0574017555947894,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.44 [0.97-2.12],0.0683593304471759,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL6,Interleukin-6,Inverse variance weighted,6,1.13 [0.99-1.29],0.0759968451161139,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.91 [0.83-1.01],0.0820488834122703,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.59 [0.94-2.69],0.0841818490753638,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.89 [0.78-1.02],0.0870923982734545,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.73 [0.5-1.05],0.0895052516205848,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPON2,Spondin-2,Inverse variance weighted,3,1.42 [0.94-2.14],0.0923803191709757,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.13 [0.98-1.31],0.0949817444950579,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.06 [0.99-1.13],0.0960499146738283,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.23 [0.96-1.57],0.0995403000715082,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EPO,Erythropoietin,Inverse variance weighted,11,0.87 [0.73-1.03],0.100079659042453,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.14 [0.98-1.33],0.10148703927569,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.75 [0.54-1.06],0.102816779070938,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.89 [0.78-1.02],0.104792303351385,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.73 [0.49-1.08],0.109674465654879,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SEPTIN8,Septin-8,Inverse variance weighted,4,1.25 [0.95-1.65],0.117453103778375,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.18 [0.96-1.46],0.120500271142587,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.03 [0.99-1.07],0.12052582066282,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AGRN,Agrin,Inverse variance weighted,14,0.87 [0.73-1.04],0.120605589903796,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,COLEC12,Collectin-12,Inverse variance weighted,3,1.52 [0.87-2.65],0.142758864360742,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NRP1,Neuropilin-1,Inverse variance weighted,14,1.15 [0.95-1.39],0.146636482415594,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.51 [0.86-2.65],0.153707158566557,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.81 [0.61-1.08],0.153860310323957,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.8 [0.6-1.09],0.155211765608981,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LGALS9,Galectin-9,Inverse variance weighted,36,1.05 [0.98-1.13],0.159211864534499,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.9 [0.77-1.04],0.162091335738432,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.17 [0.94-1.46],0.162988888554959,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.86 [0.69-1.07],0.165406668394405,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.82 [0.61-1.09],0.171053940307873,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GUCA2A,Guanylin,Inverse variance weighted,7,1.15 [0.94-1.41],0.175009358849475,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.9 [0.77-1.05],0.187379706720034,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.55 [0.23-1.34],0.19033372809314,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PALM2,Paralemmin-2,Inverse variance weighted,9,1.09 [0.96-1.23],0.205579106906063,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.04 [0.98-1.11],0.208699731951638,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.38 [0.84-2.27],0.209287972716465,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,KLK4,Kallikrein-4,Inverse variance weighted,5,0.78 [0.54-1.15],0.20993441021392,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,REN,Renin,Inverse variance weighted,8,0.8 [0.56-1.14],0.215578505244955,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.82 [0.6-1.12],0.216036065026174,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.87 [0.7-1.08],0.216510791449235,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.91 [0.79-1.05],0.218416584445248,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GAST,Gastrin,Inverse variance weighted,9,0.89 [0.74-1.07],0.229472144379211,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.88 [0.72-1.08],0.231424043408182,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.23 [0.87-1.72],0.236334370132856,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.88 [0.72-1.09],0.241302292563075,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPON1,Spondin-1,Inverse variance weighted,4,1.2 [0.88-1.64],0.243171818328569,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CTSL,Cathepsin L1,Inverse variance weighted,29,0.94 [0.85-1.04],0.244095027260416,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.16 [0.9-1.5],0.245062572848645,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.91 [0.78-1.07],0.252971128990696,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD302,CD302 antigen,Inverse variance weighted,11,0.91 [0.77-1.07],0.255712866511274,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PSAP,Prosaposin,Inverse variance weighted,13,0.93 [0.83-1.05],0.255827142287048,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.92 [0.8-1.06],0.258920170011838,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.16 [0.9-1.49],0.259068084774175,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,1.16 [0.9-1.49],0.259640698080337,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.04 [0.97-1.12],0.261368173720166,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AMBP,Protein AMBP,Inverse variance weighted,5,1.11 [0.93-1.33],0.263429399516808,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.86 [0.67-1.12],0.263973280668088,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NFASC,Neurofascin,Inverse variance weighted,6,0.81 [0.56-1.18],0.269540957379829,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.05 [0.96-1.15],0.275862402461198,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.17 [0.88-1.56],0.276248586754369,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.06 [0.95-1.18],0.28231806220722,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,11,1.08 [0.94-1.23],0.284252971914824,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHGA,Chromogranin-A,Inverse variance weighted,5,0.89 [0.71-1.11],0.29433793179795,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.94 [0.85-1.05],0.296561227442686,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.21 [0.84-1.72],0.301595279927616,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.9 [0.73-1.1],0.30572115821955,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.14 [0.89-1.45],0.316061291704557,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.84 [0.59-1.19],0.325581595891904,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.06 [0.95-1.18],0.337146907794153,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.07 [0.93-1.22],0.347101356630898,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DSC2,Desmocollin-2,Inverse variance weighted,16,0.96 [0.88-1.05],0.3647378679053,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.8 [0.49-1.31],0.368249648125611,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.1 [0.9-1.34],0.370417353808491,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.92 [0.76-1.11],0.374689266265882,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LMNB2,Lamin-B2,Inverse variance weighted,8,1.11 [0.88-1.4],0.380149789870007,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.92 [0.76-1.12],0.392229565795693,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.82 [0.52-1.29],0.392474557830926,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.14 [0.84-1.54],0.395540192817745,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GHR,Growth hormone receptor,Inverse variance weighted,26,0.95 [0.84-1.07],0.396275790424031,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.94 [0.82-1.09],0.40662283992476,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AREG,Amphiregulin,Inverse variance weighted,5,1.12 [0.85-1.48],0.407518262473058,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.88 [0.64-1.2],0.421612598037152,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.88 [0.65-1.2],0.431619946779969,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,0.96 [0.85-1.07],0.433866599200899,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.93 [0.76-1.12],0.43655375520318,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.85 [0.55-1.29],0.439149848884745,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.74 [0.34-1.6],0.44536575501188,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.19 [0.76-1.86],0.449975007685386,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.19 [0.76-1.86],0.458836404299433,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.06 [0.91-1.24],0.471237203376625,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLEC3B,Tetranectin,Inverse variance weighted,2,1.22 [0.7-2.11],0.478269752295034,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SDC1,Syndecan-1,Inverse variance weighted,12,1.08 [0.88-1.32],0.479677419010555,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.94 [0.78-1.13],0.482123672442871,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.28 [0.64-2.55],0.483729724232328,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PGF,Placenta growth factor,Inverse variance weighted,5,0.86 [0.56-1.33],0.495076758680726,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.1 [0.84-1.45],0.498994376076143,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.95 [0.81-1.11],0.502681057083132,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.08 [0.86-1.35],0.50383555319671,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,1.06 [0.9-1.25],0.504400040135134,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.9 [0.65-1.24],0.505848578490998,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.06 [0.9-1.25],0.509581871108351,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.03 [0.94-1.13],0.512707995420634,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.08 [0.86-1.35],0.514690505202894,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.96 [0.84-1.09],0.526990066781236,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.91 [0.67-1.23],0.529026735042478,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LAYN,Layilin,Inverse variance weighted,3,1.14 [0.75-1.73],0.54488808083712,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.1 [0.8-1.5],0.561259874706762,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.87 [0.54-1.4],0.561856454078234,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.14 [0.73-1.77],0.56613488045699,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NRP2,Neuropilin-2,Inverse variance weighted,14,1.06 [0.87-1.28],0.577403889899898,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PRSS8,Prostasin,Inverse variance weighted,14,0.96 [0.83-1.11],0.578899817303161,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.12 [0.75-1.67],0.579302317079014,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.06 [0.87-1.28],0.579353130810831,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.05 [0.88-1.25],0.580704198976055,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.04 [0.89-1.23],0.589799414103461,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.09 [0.8-1.49],0.590476794563742,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.05 [0.88-1.25],0.596011676511611,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.94 [0.77-1.17],0.59667499192844,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD27,CD27 antigen,Inverse variance weighted,9,0.92 [0.68-1.25],0.599380131364234,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.18 [0.64-2.16],0.600682793212118,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.95 [0.77-1.17],0.605094693027333,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.94 [0.75-1.19],0.61468779520156,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.1 [0.76-1.61],0.61581997515157,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.96 [0.82-1.12],0.616003392888099,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,0.95 [0.76-1.18],0.618686471013271,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.01 [0.96-1.07],0.62488316726788,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,F10,Coagulation factor X,Inverse variance weighted,11,0.97 [0.85-1.1],0.635359206485616,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.13 [0.69-1.85],0.637047414245051,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.08 [0.79-1.47],0.64577734353032,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.89 [0.53-1.48],0.646807623249777,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.05 [0.86-1.27],0.657221716210945,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.08 [0.76-1.54],0.660483760810747,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.95 [0.75-1.21],0.666063409936025,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CSTB,Cystatin-B,Inverse variance weighted,23,0.99 [0.93-1.05],0.667096732603469,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.04 [0.88-1.21],0.670963291683554,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.05 [0.83-1.34],0.673977313515073,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.07 [0.78-1.46],0.676970385086943,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.94 [0.69-1.27],0.677863551713416,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.97 [0.85-1.11],0.681278090848763,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EGFLAM,Pikachurin,Wald ratio,1,0.81 [0.3-2.22],0.682769132792435,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PTN,Pleiotrophin,Inverse variance weighted,3,1.07 [0.77-1.48],0.694440449784066,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.93 [0.64-1.35],0.704141916872008,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NECTIN2,Nectin-2,Inverse variance weighted,3,1.1 [0.67-1.8],0.706072521728932,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.87 [0.42-1.81],0.706542239870152,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.03 [0.87-1.22],0.710780594721533,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.01 [0.95-1.07],0.714242902409866,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,1.03 [0.89-1.18],0.723036959914309,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.07 [0.73-1.56],0.726613557741759,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.04 [0.84-1.29],0.728852529428718,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.9 [0.51-1.59],0.729309795716835,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.06 [0.77-1.46],0.734655495192733,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.05 [0.79-1.4],0.735409143854425,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.03 [0.87-1.22],0.735626459125957,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,AOC3,Membrane primary amine oxidase,Inverse variance weighted,34,0.99 [0.94-1.04],0.736188276739724,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.05 [0.78-1.42],0.746577576133064,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CST3,Cystatin-C,Inverse variance weighted,3,1.08 [0.67-1.73],0.75366700112107,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,0.96 [0.76-1.22],0.756342409867857,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.01 [0.96-1.06],0.758340540422125,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.94 [0.62-1.41],0.758953035368324,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.06 [0.72-1.57],0.761573895640396,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.96 [0.71-1.28],0.765433116653479,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,38,0.99 [0.91-1.07],0.769154587342317,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.91 [0.45-1.81],0.77888234051461,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.98 [0.88-1.1],0.785980026695963,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.96 [0.74-1.26],0.786200342520368,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.95 [0.64-1.4],0.786415944510222,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.99 [0.9-1.08],0.790071509353716,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.98 [0.81-1.17],0.797784367897215,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.98 [0.85-1.13],0.80766724009052,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.02 [0.83-1.26],0.81615472338015,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.94 [0.57-1.55],0.816177561819704,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.93 [0.49-1.76],0.823969966278765,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.95 [0.62-1.47],0.831142934138315,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.02 [0.84-1.25],0.838810605632104,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MMP7,Matrilysin,Wald ratio,1,1.03 [0.78-1.36],0.840950702835694,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1.01 [0.93-1.09],0.847859906963462,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.99 [0.84-1.16],0.857545572992377,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.97 [0.67-1.4],0.861549753550814,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PRL,Prolactin,Inverse variance weighted,7,0.96 [0.64-1.45],0.862791408056341,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.94 [0.45-1.98],0.872152052398352,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.99 [0.84-1.15],0.873593399738941,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.03 [0.68-1.57],0.878666829818676,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.01 [0.9-1.13],0.882352396330718,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.99 [0.87-1.12],0.893542270563682,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.02 [0.73-1.43],0.894918498896587,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.01 [0.84-1.22],0.89732152212162,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,F7,Coagulation factor VII,Inverse variance weighted,10,0.99 [0.82-1.19],0.899914608976759,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.98 [0.71-1.36],0.901953982069848,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.01 [0.84-1.22],0.904171121384437,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.02 [0.74-1.41],0.909519018103271,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1 [0.92-1.09],0.910154997610129,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.98 [0.67-1.43],0.910747036855269,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.01 [0.9-1.12],0.911714444890826,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.96 [0.45-2.03],0.915487973402247,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.02 [0.68-1.53],0.921164240259993,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,RSPO3,R-spondin-3,Inverse variance weighted,5,1.01 [0.78-1.32],0.925118785967322,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.02 [0.68-1.52],0.933170100861108,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.99 [0.74-1.33],0.937090947970704,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.99 [0.86-1.15],0.938008151857717,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,THBS2,Thrombospondin-2,Inverse variance weighted,15,1 [0.89-1.13],0.951465997009503,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1 [0.87-1.14],0.954686087889762,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.02 [0.46-2.26],0.954692008027855,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1 [0.88-1.12],0.954907446677905,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,WNT9A,Protein Wnt-9a,Wald ratio,1,0.98 [0.42-2.29],0.960628326196782,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CDH2,Cadherin-2,Inverse variance weighted,21,1 [0.89-1.13],0.963369920239159,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1 [0.83-1.2],0.966688256136549,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,CHGB,Secretogranin-1,Inverse variance weighted,7,1 [0.8-1.24],0.971246712723526,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1 [0.86-1.17],0.975309340570433,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1 [0.8-1.24],0.978671892741051,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,DLL1,Delta-like protein 1,Inverse variance weighted,6,1 [0.76-1.32],0.99502402301691,trans
Chapter IX Diseases of the circulatory system,I9_PAROXTAC,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1 [0.79-1.26],0.997948373485128,trans
